EP0833603A2 - Preparation de deodorant - Google Patents

Preparation de deodorant

Info

Publication number
EP0833603A2
EP0833603A2 EP96917331A EP96917331A EP0833603A2 EP 0833603 A2 EP0833603 A2 EP 0833603A2 EP 96917331 A EP96917331 A EP 96917331A EP 96917331 A EP96917331 A EP 96917331A EP 0833603 A2 EP0833603 A2 EP 0833603A2
Authority
EP
European Patent Office
Prior art keywords
concentrate
preparation according
deodorant preparation
liquid
deodorant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP96917331A
Other languages
German (de)
English (en)
Inventor
Wolfgang Weiland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE29623632U priority Critical patent/DE29623632U1/de
Publication of EP0833603A2 publication Critical patent/EP0833603A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A61K8/0225—Granulated powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions

Definitions

  • the invention relates to a deodorant preparation which contains at least one antiperspirant substance which is water-soluble.
  • the invention relates to a method for producing a deodorant preparation, in which a concentrate is mixed with a liquid.
  • deodorants are usually sold as finished products to the end user.
  • liquid deodorants are known which are sprayable in the case of a low-viscosity design.
  • Viscous deodorants are also known, which are used, for example, in deodorant rollers come.
  • deodorant sticks are formed and finally solid crystals are known which are also used as deodorants.
  • Such crystals consist of ammonium alum, for example.
  • the liquid deodorants have the disadvantage that the known packaging units cannot be refilled.
  • the known packaging units are usually provided with a volume, which leads to a loss of quality of the product due to irregular use due to aging.
  • the crystalline deodorants are extremely brittle and shatter when subjected to mechanical loads, for example after falling on a floor. The resulting crystal splinters are sharp-edged and can cause injuries. It is therefore no longer possible to use a destroyed deodorant crystal.
  • the object of the present invention is therefore to design a deodorant of the type mentioned in the introduction in such a way that a preparation of a usable end product is supported by the consumer.
  • the antiperspirant substance is formed as a concentrate.
  • Another object of the present invention is to design a method of the type mentioned in the introduction such that an individual preparation is supported by a user. According to the invention, this object is achieved in that the concentrate is portioned and the liquid is added in the area of intended use.
  • the antiperspirant substance as a preparation, it is possible to take only a small packaging volume on the transport route from the manufacturer to the consumer, which on the one hand saves transport costs and on the other hand considerably reduces the amount of packaging.
  • the respective user can always prepare the amount of substance that is intended for early consumption. This ensures a permanent high quality of use of the product.
  • the prepared end product can be filled in different containers.
  • atomizers or rolling pins are intended.
  • the concentrate is in the form of a compressed powder in the form of a tablet.
  • a distribution in the absorbing liquid can also be supported by the fact that the concentrate is in the form of a compressed granulate in the form of a tablet.
  • the concentrate is designed as a liquid arranged in a soluble shell.
  • the concentrate be in the form of a powder arranged in a soluble shell. It is also contemplated that the concentrate is formed as a granulate arranged in a soluble shell.
  • the casing is designed as an openable container.
  • FIG. 1 shows a schematic representation of a tablet-like concentrate
  • FIG. 2 shows a cross section through a concentrate which is introduced into an outer shell.
  • the tablet (1) which is formed from a compressed solid concentrate (2).
  • the concentrate can be, for example, powdery or granular.
  • a corresponding one The pressing process is to be carried out in such a way that the tablet (1) is adequately dimensionally stable, but on the other hand a dissolving process in a liquid, for example in water, is not impaired by excessive material strength.
  • the concentrate (2) consists essentially of an antiperspirant substance. Additives can be added to this substance. For example, smell substances or skin care additives, for example plant extracts, are intended.
  • the tablet (1) has a dimensioning that makes it possible to produce the end product together with a predetermined amount of liquid. It is possible to adjust the pH of the end product via the concentration or with the aid of further additives. In particular, a pH value in the interval from 4.5 to 6.0 is thought of. The pH is preferably 5.5.
  • the concentrate (2) is arranged here in an outer shell (3).
  • the concentrate (2) can be liquid and the casing (3) consists of a substance that is soluble in the preparation liquid provided.
  • the shell (3) is water-soluble.
  • substances can be used which are also common in medical applications for encapsulated products.
  • the concentrate (2) arranged in the shell (3) in powder form. After the shell (2) has been opened, the preferably loose powder can be distributed in the liquid and the dissolving process can be carried out quickly.
  • liquid concentrates (2) as an alternative to a dissolving process, it is also intended to produce emulsions.
  • the concentrate (2) can be liquid or powdery, for example, and is poured out of the torn shell (3) into the area of the intended liquid and distributed or dissolved in the liquid by stirring or shaking.
  • the concentrate (2) is given a rod-shaped configuration.
  • the rod-shaped concentrate preferably has
  • the rod-shaped design of the concentrate (2) makes it easy to insert it into a commercially available atomizer (4).
  • the concentrate (2) being in the form of a tablet (1), it is also possible in the case of a rod-shaped design, optionally a casing
  • a further measure to increase the quality of use is to add alcohol present in solid form to the concentrate (2) or to add substances which initially have a solid consistency and split off alcohol after contact with the liquid.
  • lime-containing liquids for example tap water
  • an acid component for example, adding citric acid is contemplated.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

La préparation de déodorant comprend au moins une substance empêchant la transpiration qui est soluble dans l'eau. La préparation de déodorant est conçue sous forme de concentré. Dans le domaine d'utilisation prévu, le concentré est conçu pour être soluble dans une quantité correspondante d'eau pour former un produit final.
EP96917331A 1995-06-07 1996-06-04 Preparation de deodorant Ceased EP0833603A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE29623632U DE29623632U1 (de) 1995-06-07 1996-06-04 Deodorantpräparat

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1995120789 DE19520789A1 (de) 1995-06-07 1995-06-07 Deodorantpräparat
DE19520789 1995-06-07
PCT/DE1996/000982 WO1996040046A2 (fr) 1995-06-07 1996-06-04 Preparation de deodorant

Publications (1)

Publication Number Publication Date
EP0833603A2 true EP0833603A2 (fr) 1998-04-08

Family

ID=7763832

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96917331A Ceased EP0833603A2 (fr) 1995-06-07 1996-06-04 Preparation de deodorant

Country Status (4)

Country Link
EP (1) EP0833603A2 (fr)
AU (1) AU5995996A (fr)
DE (1) DE19520789A1 (fr)
WO (1) WO1996040046A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2626323A (en) * 2023-01-17 2024-07-24 Roller Deo Ltd Hygiene composition dispensable using apparatus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3471611A (en) * 1967-07-17 1969-10-07 Del Lab Compressed cosmetic powder article with fragile protective film adhered on exposed surface thereof
JPH0236114A (ja) * 1988-07-22 1990-02-06 Kenji Nakamura 化粧用シートおよびその製造方法
JPH069357A (ja) * 1992-06-25 1994-01-18 Ruibosuteii Japan:Kk 体臭・排泄物の悪臭除去剤
GB9322962D0 (en) * 1993-11-08 1994-01-05 Gillette Co Antiperspirants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9640046A3 *

Also Published As

Publication number Publication date
WO1996040046A2 (fr) 1996-12-19
WO1996040046A3 (fr) 1997-02-06
AU5995996A (en) 1996-12-30
DE19520789A1 (de) 1996-12-12

Similar Documents

Publication Publication Date Title
DE69821346T2 (de) Partikelförmiger gelträger für topisch applizierte aktive substanzen
DE68901739T2 (de) Emulsion aus gelpartikeln und diese enthaltende zusammensetzung.
EP1161221A1 (fr) Procede de production de formulations cosmetiques ou pharmaceutiques par micromelange juste avant utilisation
EP1159076B1 (fr) Systeme d'emballage pour formulations cosmetiques
DE3530902A1 (de) Kosmetische zusammensetzung, insbesondere zu dekorativen zwecken
DE202005011885U1 (de) Geschäumte Zubereitung
EP0011263A1 (fr) Composition aérosol, procédé de préparation d'une telle composition et appareil pour la mise en oeuvre de ce procédé
DE102007022255B4 (de) Ausgabeöffnungsplatte für optisch attraktive Antitranspirant Formulierungen
WO1996040046A2 (fr) Preparation de deodorant
DE2843517A1 (de) Handwaschpraeparat
DE10221863A1 (de) Phospholipidische Zusammensetzung sowie deren Verwendung
DE69523461T2 (de) Auflösungssystem für eine wirkstoffhaltige flüssige lösung
DE29623632U1 (de) Deodorantpräparat
DE102005035398A1 (de) Geschäumte Zubereitung
DE60025806T2 (de) Verfahren zur herstellung von weinstein und natriumbicarbonat enthaltenden kosmetische zubereitungen
EP2260904A1 (fr) Procédé de mélange de parfum
EP2748271B1 (fr) Corps moulé abrasif contre les démangeaisons
DE690997C (de) schen Pflanzen
EP2671615A1 (fr) Additif solide de bain avec un profil de dissémination visuel et olfactoric à l'effect retardé
EP0572589A1 (fr) Produit liquide protege contre la deterioration et procede de protection de produits liquides contre la deterioration
DE102008053303B4 (de) Verfahren zur Herstellung fettarmer, milchtrockenprodukthaltiger Schokolade mittels Mahlkörpermühle
WO2018086790A1 (fr) Mousse nettoyante contenant de l'hydroxypropylméthylcellulose et de la gomme xanthane
DE19958612B4 (de) Lipidische Zusammensetzung und deren Verwendung, sowie die Verwendung von Neopentansäureester, n-Octadecansäure-12-[(1-oxo-octadecyl)oxy]-ester oder eine Kombination aus beiden als Lösungsmittel
DE19910697C2 (de) Verfahren zur Herstellung einer therapeutisch wirksamen Substanz und Verwendung derselben
EP2683448B1 (fr) Mousse contenant un agent actif, un protéin et un ester d'un acide gras et procédé de préparation correspondante

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980922

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20001216